Detection of human parvovirus B19-specific IgM and IgG antibodies using a recombinant viral VP1 antigen expressed in insect cells and estimation of time of infection by testing for antibody avidity

This publication has 16 references indexed in Scilit:

• Avidity of IgG antibodies to human herpesvirus‐6 distinguishes primary from recurrent infection in organ transplant recipients and excludes cross‐reactivity with other herpesviruses
  Journal of Medical Virology, 1993
• Prospective study of human parvovirus (B19) infection in pregnancy. Public Health Laboratory Service Working Party on Fifth Disease.
  BMJ, 1990
• Antigenic parvovims B19 coat proteins VP1 and VP2 produced in large quantities in a baculovirus expression system
  Virus Research, 1990
• Immunoglobulin G avidity in Epstein-Barr virus infections in organ transplant recipients
  Serodiagnosis and Immunotherapy in Infectious Disease, 1989
• Pure Red-Cell Aplasia of 10 Years' Duration Due to Persistent Parvovirus B19 Infection and Its Cure with Immunoglobulin Therapy
  New England Journal of Medicine, 1989
• SEROLOGICAL DISTINCTION BETWEEN PRIMARY RUBELLA AND REINFECTION
  The Lancet, 1988
• RUBELLA INFECTION AND REINFECTION DISTINGUISHED BY AVIDITY OF IgG
  The Lancet, 1988
• HUMAN PARVOVIRUS-ASSOCIATED ARTHRITIS: A CLINICAL AND LABORATORY DESCRIPTION
  The Lancet, 1985
• A search for a characteristic illness in children with serological evidence of viral or toxoplasma infection: Epstein Barr Virus, Hepatitis A, Human Polyomaviruses BK and JC, Parvovirus-like B19 and Toxoplasma
  Journal of Infection, 1981
• Description of a technique for the determination of the concentration and quality of rubella virus antibody molecules and experience with testing sera from humans with recent and past rubella infection
  Archiv für die gesamte Virusforschung, 1980